Clinical Trial

KOrea COpd Subgroup Registry and Subtype Research

Study acronym: KOCOSS
Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
The KOrea COpd Subgroup Study team (KOCOSS) cohort is an ongoing, longitudinal, prospective, non-interventional and observational study within the Korean COPD patients. The prevalence of early COPD (mild to moderate COPD based by 2011 GOLD(the Global Initiative for Chronic Obstructive Lung Disease) guideline) is high in Korea. However, the patients with early COPD are not underdiagnosed due to mild symptom. The purpose of this study is to investigate early COPD characteristics and disease course and to form a guideline for early detection of COPD patients and prevention of progression to severe COPD.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2042-02 -> 2042-12-31 2026-08-11
minor Completion pushed: 2042-02 -> 2042-12-31 2026-08-11
Trial Details
NCT Number NCT02800499
Lead Sponsor Konkuk University Medical Center
Conditions COPD
Enrollment 2,000 participants
Start Date 2011-12-01
Primary Completion 2042-12-31 (estimated)
Study Completion 2042-12-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-10